Journal of Pharmaceutical Investigation
- Volume 31 Issue 4
- /
- Pages.281-287
- /
- 2001
- /
- 2093-5552(pISSN)
- /
- 2093-6214(eISSN)
Bioequivalence of Rebamide Tablet to Mucosta Tablet (Rebamipide 100 mg)
무코스타 정(레바미피드 100 mg)에 대한 레바미드 정의 생물학적 동등성
- Cho, Hea-Young (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
- Jeong, Hyun-Cheol (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
- Oh, In-Joon (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
- Moon, Jai-Dong (Medical School, Chonnam National University) ;
-
Lee, Yong-Bok
(College of Pharmacy and Research Institute of Drug Development, Chonnam National University)
- 조혜영 (전남대학교 약학대학/약품개발연구소) ;
- 정현철 (전남대학교 약학대학/약품개발연구소) ;
- 오인준 (전남대학교 약학대학/약품개발연구소) ;
- 문재동 (전남대학교 의과대학) ;
-
이용복
(전남대학교 약학대학/약품개발연구소)
- Published : 2001.12.20
Abstract
Rebamipide is a novel anti-gastric ulcer agent that has been reported to increase the synthesis of mucus, to increase the mucosal concentration of prostaglandin, and to promote rapid ulcer healing. The purpose of the present study was to evaluate the bioequivalence of two rebamipide tablets,